Status:
COMPLETED
Suicide Prevention for Patients With Chronic Pain
Lead Sponsor:
Veterans BioMedical Research Institute
Collaborating Sponsors:
Rutgers University
Conditions:
Suicide
Chronic Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, ob...
Detailed Description
Every day, 120 people die from suicide, that is one person every 15 minutes.1 Suicide prevention treatments focus on those at highest risk and are primarily delivered as mental health treatments,2-5 a...
Eligibility Criteria
Inclusion
- Inclusion criteria will include:
- has a VA primary care provider and has had an in-person visit with a VA provider in the past year;
- pain that is (b1) musculoskeletal, defined as regional (joints, limbs, back, neck) or more generalized (chronic widespread pain);
- pain that is (b2) moderately severe, defined as a Brief Pain Inventory (BPI) intensity item score of 5 or higher for either "average" or "worst" pain in the past week;
- pain that is (b3) persistent, (i.e., ≥3 months)
- active suicidal ideation defined as scoring a 2 to 4 on the C-SSRS.
- Exclusion Criteria:
- life-threatening condition
- severe cognitive impairment
- psychotic disorder
- pregnant or plans to become pregnant in the next year
- suicide attempt in the past year or hospitalization for suicide risk in the past year
Exclusion
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 27 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04490265
Start Date
May 20 2020
End Date
December 27 2023
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA NJHCS
East Orange, New Jersey, United States, 07018